Class III
Ongoing
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Why: Failed Impurities/Degradation Specifications
- Company
- SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States - Reported
- Jul 8, 2026
- Recall started
- Jun 1, 2026
- Where sold
- U.S. Nationwide
- Amount
- 9,048 bottles
- Full product description
- Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
- Lots / codes affected
- Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.